LUSEVE Trademark

Trademark Overview

On Thursday, May 22, 2014, a trademark application was filed for LUSEVE with the United States Patent and Trademark Office. The USPTO has given the LUSEVE trademark a serial number of 86289457. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 11, 2024. This trademark is owned by Glaxo Group Limited. The LUSEVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
luseve

General Information

Serial Number86289457
Word MarkLUSEVE
Filing DateThursday, May 22, 2014
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 11, 2024
Registration Number5430687
Registration DateTuesday, March 27, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 9, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 11, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxo Group Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB
Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS

Trademark Events

Event DateEvent Description
Monday, May 26, 2014NEW APPLICATION ENTERED
Thursday, June 5, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 6, 2014ASSIGNED TO EXAMINER
Monday, September 8, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 1, 2015SOU TEAS EXTENSION RECEIVED
Monday, June 1, 2015SOU EXTENSION 1 FILED
Monday, June 1, 2015SOU EXTENSION 1 GRANTED
Wednesday, June 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 24, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 14, 2014PUBLISHED FOR OPPOSITION
Tuesday, October 14, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 9, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, November 18, 2015SOU EXTENSION 2 FILED
Monday, December 14, 2015SOU EXTENSION 2 GRANTED
Tuesday, December 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, May 31, 2016SOU EXTENSION 3 FILED
Friday, June 10, 2016SOU EXTENSION 3 GRANTED
Saturday, June 11, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 3, 2016ASSIGNED TO EXAMINER
Thursday, December 1, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, June 23, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, November 18, 2015SOU TEAS EXTENSION RECEIVED
Friday, December 11, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 31, 2016SOU TEAS EXTENSION RECEIVED
Monday, June 19, 2017SOU EXTENSION 5 GRANTED
Thursday, December 1, 2016SOU EXTENSION 4 FILED
Wednesday, January 4, 2017SOU EXTENSION 4 GRANTED
Thursday, January 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 2, 2017SOU TEAS EXTENSION RECEIVED
Friday, June 2, 2017SOU EXTENSION 5 FILED
Wednesday, June 7, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 14, 2017NOTICE OF ALLOWANCE CANCELLED
Wednesday, November 29, 2017ASSIGNED TO PETITION STAFF
Friday, December 1, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Tuesday, January 9, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 27, 2018REGISTERED-PRINCIPAL REGISTER
Monday, December 9, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 9, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, November 8, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 8, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 20, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 14, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Monday, December 4, 2017NOA CANCELLED; REPUBLICATION REQUIRED
Wednesday, December 20, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 9, 2018PUBLISHED FOR OPPOSITION
Tuesday, November 8, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 8, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, March 27, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, October 11, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

luseve pharmaceutical treatment disorders preparations substances diseases ophthalmic respiratory hepatological oncological